490 related articles for article (PubMed ID: 26398286)
21. Chromosomal instability upregulates interferon in acute myeloid leukemia.
Jin N; Lera RF; Yan RE; Guo F; Oxendine K; Horner VL; Hu Y; Wan J; Mattison RJ; Weaver BA; Burkard ME
Genes Chromosomes Cancer; 2020 Nov; 59(11):627-638. PubMed ID: 32557940
[TBL] [Abstract][Full Text] [Related]
22. A unique hinge binder of extremely selective aminopyridine-based Mps1 (TTK) kinase inhibitors with cellular activity.
Kusakabe K; Ide N; Daigo Y; Itoh T; Yamamoto T; Kojima E; Mitsuoka Y; Tadano G; Tagashira S; Higashino K; Okano Y; Sato Y; Inoue M; Iguchi M; Kanazawa T; Ishioka Y; Dohi K; Kido Y; Sakamoto S; Ando S; Maeda M; Higaki M; Yoshizawa H; Murai H; Nakamura Y
Bioorg Med Chem; 2015 May; 23(9):2247-60. PubMed ID: 25801152
[TBL] [Abstract][Full Text] [Related]
23. Preferential killing of p53-deficient cancer cells by reversine.
Jemaà M; Galluzzi L; Kepp O; Boilève A; Lissa D; Senovilla L; Harper F; Pierron G; Berardinelli F; Antoccia A; Castedo M; Vitale I; Kroemer G
Cell Cycle; 2012 Jun; 11(11):2149-58. PubMed ID: 22592527
[TBL] [Abstract][Full Text] [Related]
24. Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells.
Min A; Kim JE; Kim YJ; Lim JM; Kim S; Kim JW; Lee KH; Kim TY; Oh DY; Bang YJ; Im SA
Cancer Lett; 2018 Aug; 430():123-132. PubMed ID: 29729292
[TBL] [Abstract][Full Text] [Related]
25. Understanding inhibitor resistance in Mps1 kinase through novel biophysical assays and structures.
Hiruma Y; Koch A; Hazraty N; Tsakou F; Medema RH; Joosten RP; Perrakis A
J Biol Chem; 2017 Sep; 292(35):14496-14504. PubMed ID: 28726638
[TBL] [Abstract][Full Text] [Related]
26. The Saccharomyces cerevisiae spindle pole body duplication gene MPS1 is part of a mitotic checkpoint.
Weiss E; Winey M
J Cell Biol; 1996 Jan; 132(1-2):111-23. PubMed ID: 8567717
[TBL] [Abstract][Full Text] [Related]
27. Mps1 kinase regulates tumor cell viability via its novel role in mitochondria.
Zhang X; Ling Y; Guo Y; Bai Y; Shi X; Gong F; Tan P; Zhang Y; Wei C; He X; Ramirez A; Liu X; Cao C; Zhong H; Xu Q; Ma RZ
Cell Death Dis; 2016 Jul; 7(7):e2292. PubMed ID: 27383047
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation at threonine 288 by cell cycle checkpoint kinase 2 (CHK2) controls human monopolar spindle 1 (Mps1) kinetochore localization.
Yeh CW; Yu ZC; Chen PH; Cheng YC; Shieh SY
J Biol Chem; 2014 May; 289(22):15319-27. PubMed ID: 24764296
[TBL] [Abstract][Full Text] [Related]
29. Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature.
Knudsen ES; Hutcheson J; Vail P; Witkiewicz AK
Oncotarget; 2017 Jul; 8(27):43678-43691. PubMed ID: 28620137
[TBL] [Abstract][Full Text] [Related]
30. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT
Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402
[TBL] [Abstract][Full Text] [Related]
31. Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.
Thu KL; Silvester J; Elliott MJ; Ba-Alawi W; Duncan MH; Elia AC; Mer AS; Smirnov P; Safikhani Z; Haibe-Kains B; Mak TW; Cescon DW
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1570-E1577. PubMed ID: 29378962
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma.
Szymiczek A; Carbone M; Pastorino S; Napolitano A; Tanji M; Minaai M; Pagano I; Mason JM; Pass HI; Bray MR; Mak TW; Yang H
Oncogene; 2017 Nov; 36(46):6501-6507. PubMed ID: 28759042
[TBL] [Abstract][Full Text] [Related]
33. Differential properties of mitosis-associated events following CHK1 and WEE1 inhibitor treatments in human tongue carcinoma cells.
Nojima H; Homma H; Onozato Y; Kaida A; Harada H; Miura M
Exp Cell Res; 2020 Jan; 386(2):111720. PubMed ID: 31738907
[TBL] [Abstract][Full Text] [Related]
34. MPS1-dependent mitotic BLM phosphorylation is important for chromosome stability.
Leng M; Chan DW; Luo H; Zhu C; Qin J; Wang Y
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11485-90. PubMed ID: 16864798
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of Mps1 in colon cancer cells attenuates the spindle assembly checkpoint and increases aneuploidy.
Ling Y; Zhang X; Bai Y; Li P; Wei C; Song T; Zheng Z; Guan K; Zhang Y; Zhang B; Liu X; Ma RZ; Cao C; Zhong H; Xu Q
Biochem Biophys Res Commun; 2014 Aug; 450(4):1690-5. PubMed ID: 25063032
[TBL] [Abstract][Full Text] [Related]
36. Autophosphorylation-dependent activation of human Mps1 is required for the spindle checkpoint.
Kang J; Chen Y; Zhao Y; Yu H
Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20232-7. PubMed ID: 18083840
[TBL] [Abstract][Full Text] [Related]
37. Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs.
Tannous BA; Kerami M; Van der Stoop PM; Kwiatkowski N; Wang J; Zhou W; Kessler AF; Lewandrowski G; Hiddingh L; Sol N; Lagerweij T; Wedekind L; Niers JM; Barazas M; Nilsson RJ; Geerts D; De Witt Hamer PC; Hagemann C; Vandertop WP; Van Tellingen O; Noske DP; Gray NS; Würdinger T
J Natl Cancer Inst; 2013 Sep; 105(17):1322-31. PubMed ID: 23940287
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model.
Maia AR; de Man J; Boon U; Janssen A; Song JY; Omerzu M; Sterrenburg JG; Prinsen MB; Willemsen-Seegers N; de Roos JA; van Doornmalen AM; Uitdehaag JC; Kops GJ; Jonkers J; Buijsman RC; Zaman GJ; Medema RH
Ann Oncol; 2015 Oct; 26(10):2180-92. PubMed ID: 26153498
[TBL] [Abstract][Full Text] [Related]
39. Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity.
Kusakabe K; Ide N; Daigo Y; Itoh T; Yamamoto T; Hashizume H; Nozu K; Yoshida H; Tadano G; Tagashira S; Higashino K; Okano Y; Sato Y; Inoue M; Iguchi M; Kanazawa T; Ishioka Y; Dohi K; Kido Y; Sakamoto S; Ando S; Maeda M; Higaki M; Baba Y; Nakamura Y
J Med Chem; 2015 Feb; 58(4):1760-75. PubMed ID: 25625617
[TBL] [Abstract][Full Text] [Related]
40. The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro.
Tanaka S; Suzuki K; Sakaguchi M
Breast Cancer; 2017 Sep; 24(5):658-666. PubMed ID: 28070831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
